Systemic treatment of psoriatic patients with bexarotene dec…
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation%2525252C and improves differentiation in lesional skin.
Article, Chapter
Authors:
J.V.
Publication:
Volume:51,
Issue:2,
Page(s):257-264
Published:
2004
We were unable to find direct full text links for this item.